Loading data
CLRONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 328 k USD | 194 k USD | 12.35 m USD | 15.75 m USD | 17.05 m USD |
| Gross profit | -328 k USD | -194 k USD | 6.36 m USD | 9.46 m USD | 11.92 m USD |
| Research and development expense | — | 3.3 m USD | 3.67 m USD | 4.39 m USD | 5.79 m USD |
| Operating profit | -4.4 m USD | -2.14 m USD | -6.77 m USD | -7.22 m USD | -7.5 m USD |
| Interest expense | — | — | 537 k USD | 420 k USD | 514 k USD |
| Profit before tax | -4.54 m USD | -1.75 m USD | -126 k USD | 27.46 m USD | -7.98 m USD |
| Income tax expense | 83 k USD | 98 k USD | 434 k USD | 6.9 m USD | -283 k USD |
| Net income (reported basis) | -26.08 m USD | -8.98 m USD | -560 k USD | 20.56 m USD | -7.69 m USD |
| Basic earnings per share | -14.77 USD/share | -5.61 USD/share | -0.02 USD/share | 0.86 USD/share | -0.39 USD/share |
| Diluted earnings per share | -14.77 USD/share | -5.61 USD/share | -0.02 USD/share | 0.83 USD/share | -0.39 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.